|
Condensed Statements of Cash Flows (USD $)
|
3 Months Ended |
|
Jan. 31, 2015
|
Jan. 31, 2014
|
| Cash Flows from Operating Activities |
|
|
| Net Income |
$ 2,378,077 |
$ 7,753,542 |
| Adjustments to reconcile net income to net cash provided by operating activities |
|
|
| Depreciation and amortization |
1,715,652 |
1,644,609 |
| (Income) loss from equity method investments |
(24,810) |
78,940 |
| Change in assets and liabilities |
|
|
| Restricted marketable securities |
0 |
33,692 |
| Deposits with broker |
0 |
273,020 |
| Accounts receivable |
1,434,495 |
81,537 |
| Inventories |
(763,549) |
(1,136,921) |
| Derivative instruments |
52,471 |
(261,189) |
| Prepaids and other |
(28,898) |
39,029 |
| Customer deposits |
434,385 |
645,839 |
| Accounts payable |
(100,683) |
338,427 |
| Accrued expenses |
(252,861) |
365,874 |
| Net cash provided by operating activities |
4,844,279 |
9,856,399 |
| Cash Flows from Investing Activities |
|
|
| Capital expenditures |
(459,505) |
(181,317) |
| Investment in equity method investment |
347,400 |
(77,000) |
| Net cash used in investing activities |
(112,105) |
(258,317) |
| Cash Flows from Financing Activities |
|
|
| Payments on long-term debt |
(1,152,202) |
(2,756,629) |
| Member distributions |
(5,572,125) |
0 |
| Net cash used in financing activities |
(6,724,327) |
(2,756,629) |
| Net Increase (Decrease) in Cash and Cash Equivalents |
(1,992,153) |
6,841,453 |
| Cash and cash equivalents – Beginning of Period |
15,511,589 |
7,869,188 |
| Cash and cash equivalents – End of Period |
13,519,436 |
14,710,641 |
| Supplemental Cash Flow Information |
|
|
| Cash paid for interest expense |
246,358 |
842,633 |
| Supplemental Disclosure of Noncash Financing and Investing Activities |
|
|
| Unrealized loss on restricted marketable securities |
0 |
(1,480) |
| Capital expenditures included in accounts payable |
$ 40,684 |
$ 80,883 |